Development of A Novel Anti-Hyperglycemic Agent

NCT00878605 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

38

Enrollment

FED

Sponsor class

Stopped Unable to reach accrual target.

Conditions

Diabetes

Interventions

DRUG: Cyclo-Z
DRUG: Placebo

Sponsor

VA Office of Research and Development